Hemab Therapeutics Holdings Inc.
Tracked across 1 events · 6 articles · First seen Jul 21, 2026 · Last active Jul 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
The biotechnology sector is outperforming AI-related listings in the US IPO market, with biotech and pharmaceutical IPOs delivering a weighted average return of 55% in 2026, compared to a 4.4% weighted average loss for the…
Impact: Hemab Therapeutics Holdings Inc. has more than doubled since its IPO in May, reflecting strong investor interest.
Jul 21, 2026 · 6 articles
50
Hemab Therapeutics Holdings Inc. went publicBiotech IPO market...
ERGEN INTELLIGENCE
Track Hemab Therapeutics Holdings Inc. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard